Cytokinetics Newsroom

RBC Capital Sticks to Its Buy Rating for Cytokinetics (CYTK)

TipRanksNov 28 09:49

Cytokinetics Is Maintained at Outperform by Mizuho

Dow JonesNov 21 21:20

A Quick Look at Today's Ratings for Cytokinetics(CYTK.US), With a Forecast Between $70 to $120

Futu NewsNov 20 21:01

Cytokinetics' Hold Rating Amid Bayer Partnership and Acquisition Uncertainty

TipRanksNov 20 19:18

Cytokinetics Gains 'Buy' Rating Due to Strategic Collaborations and Potential FDA Approval

TipRanksNov 20 05:07

Cytokinetics Analyst Ratings

BenzingaNov 20 01:46

H.C. Wainwright Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $120

Futu NewsNov 19 16:42

Positive Clinical Outcomes Drive Buy Rating for Cytokinetics's Cardiac Myosin Modulators

TipRanksNov 18 19:21

Cytokinetics Analyst Ratings

BenzingaNov 12 00:02

H.C. Wainwright Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $120

Futu NewsNov 11 22:33

RBC Capital Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $80

Futu NewsNov 11 20:34

Cytokinetics (CYTK) Initiated With a Buy at RBC Capital

TipRanksNov 11 19:51

Cytokinetics: Strategic Growth and Strong Financial Positioning Drive Buy Rating

TipRanksNov 11 14:31

Needham Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $72

Futu NewsNov 9 19:34

RBC Starts Cytokinetics With Outperform Rating, $80 Price Target

MT NewswiresNov 8 21:52

A Quick Look at Today's Ratings for Cytokinetics(CYTK.US), With a Forecast Between $70 to $120

Futu NewsNov 8 21:15

Cytokinetics Price Target Maintained With a $120.00/Share by HC Wainwright & Co.

Dow JonesNov 8 04:31

Cytokinetics Analyst Ratings

BenzingaNov 8 04:21

A Quick Look at Today's Ratings for Cytokinetics(CYTK.US), With a Forecast Between $60 to $120

Futu NewsNov 7 21:11

Cytokinetics Hold Rating: Balancing Progress and Challenges Amid Uncertain Upside

TipRanksNov 7 19:55